| Product NDC: | 59762-0450 |
| Proprietary Name: | Colestipol Hydrochloride |
| Non Proprietary Name: | Colestipol Hydrochloride |
| Active Ingredient(s): | 1 g/1 & nbsp; Colestipol Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59762-0450 |
| Labeler Name: | Greenstone LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020222 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 19940719 |
| Package NDC: | 59762-0450-1 |
| Package Description: | 120 TABLET in 1 BOTTLE (59762-0450-1) |
| NDC Code | 59762-0450-1 |
| Proprietary Name | Colestipol Hydrochloride |
| Package Description | 120 TABLET in 1 BOTTLE (59762-0450-1) |
| Product NDC | 59762-0450 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Colestipol Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19940719 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Greenstone LLC |
| Substance Name | COLESTIPOL HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |